1 2 3 4 5

Side effects and tolerability of combination blood pressure lowering according to blood pressure levels: an analysis of the PROGRESS and ADVANCE trials

Atkins, Emily R.; Hirakawa, Yoichiro; Salam, Abdul; More

Journal of Hypertension . 35(6):1318-1325, June 2017.

PROX1 gene CC genotype as a major determinant of early onset of type 2 diabetes in slavic study participants from Action in Diabetes and Vascular Disease: Preterax and Diamicron...

Hamet, Pavel; Haloui, Mounsif; Harvey, François; More

Journal of Hypertension . 35:S24-S32, May 2017.

OS 05-01 PROX1 GENE CC GENOTYPE AS A MAJOR DETERMINANT OF EARLY ONSET OF T2D AND CARDIOVASCULAR COMPLICATIONS IN SLAVIC SUBJECTS FROM ADVANCE STUDY.

Hamet, Pavel; Haloui, Mounsif; Harvey, François; More

Journal of Hypertension . 34:e58, September 2016.

YIA 03-01 VALIDATION OF GENETIC DETERMINANTS OF UNMET NEEDS IN THE TREATMENT OF KIDNEY DISEASE IN TYPE-2 DIABETES.

Simon, Paul; Krajcoviechová, Aelna; Harvey, Francois; More

Journal of Hypertension . 34:e204, September 2016.

OS 34-04 SAFETY OF EARLY INTENSIVE BLOOD PRESSURE LOWERING IN CEREBRAL SMALL VESSEL DISEASE AND CHRONIC KIDNEY DISEASE IN ACUTE INTRACEREBRAL HEMORRHAGE.

Anderson, Craig; Sato, Shoichiro; Delcourt, Candice; More

Journal of Hypertension . 34:e396-e397, September 2016.

Management of the hypertensive patient with elevated heart rate: Statement of the Second Consensus Conference endorsed by the European Society of Hypertension

Palatini, Paolo; Rosei, Enrico Agabiti; Casiglia, Edoardo; More

Journal of Hypertension . 34(5):813-821, May 2016.

Risks associated with permanent discontinuation of blood pressure-lowering medications in patients with type 2 diabetes

Hirakawa, Yoichiro; Arima, Hisatomi; Webster, Ruth; More

Journal of Hypertension . 34(4):781-787, April 2016.

Clinical Practice Guidelines for the Management of Hypertension in the Community: A Statement by the American Society of Hypertension and the International Society of Hypertension

Weber, Michael A.; Schiffrin, Ernesto L.; White, William B.; More

Journal of Hypertension . 32(1):3-15, January 2014.

68 SYSTOLIC BLOOD PRESSURE VARIABILITY PREDICTS BOTH MACROVASCULAR AND MICROVASCULAR COMPLICATIONS IN TYPE 2 DIABETES: THE ADVANCE TRIAL.

Hata, Jun; Arima, Hisatomi; Rothwell, Peter M; More

Journal of Hypertension . 30:e21, September 2012.

A pharmacogenetic analysis of determinants of hypertension and blood pressure response to angiotensin-converting enzyme inhibitor therapy in patients with vascular disease and...

Brugts, Jasper J; Isaacs, Aaron; de Maat, Moniek PM; More

Journal of Hypertension . 29(3):509-519, March 2011.

The effects of blood pressure reduction and of different blood pressure-lowering regimens on major cardiovascular events according to baseline blood pressure: meta-analysis of...

Czernichow, Sébastien; Zanchetti, Alberto; Turnbull, Fiona; More

Journal of Hypertension . 29(1):4-16, January 2011.

Efficacy and safety of routine blood pressure lowering in older patients with diabetes: results from the ADVANCE trial

Ninomiya, Toshiharu; Zoungas, Sophia; Neal, Bruce; More

Journal of Hypertension . 28(6):1141-1149, June 2010.

Perindopril-based blood pressure lowering reduces major vascular events in Asian and Western participants with cerebrovascular disease: the PROGRESS trial

Arima, Hisatomi; Anderson, Craig; Omae, Teruo; More

Journal of Hypertension . 28(2):395-400, February 2010.

Efficacy and safety of fixed combination of perindopril and indapamide in type 2 diabetes: results from ADVANCE in context of available evidence

Chalmers, John; Joshi, Rohina; Kengne, Andre Pascal; More

Journal of Hypertension . 26:S21-S27, September 2008.

1 2 3 4 5